Skip to main content
Clinical Trials/TCTR20210510005
TCTR20210510005
Recruiting
Phase 1

The Efficacy of Oropharyngeal Myofunctional Exercise as an Adjunct to Titratable Mandibular Advancement Device in Treating Obstructive Sleep Apnea Patients: A Randomized Controlled Trial

Chulalongkorn University0 sites30 target enrollmentMay 10, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Obstructive sleep apnea (OSA) in patients whose AHI remains higher than 14 events per sleep hour despite the use of MAD.
Sponsor
Chulalongkorn University
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 10, 2021
End Date
March 31, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.OSA patients diagnosed with laboratory polysomnography to have OSA and have been treating with MAD, 2\.Age 18 years old or older, 3\.Residual AHI is higher than 14 events per hour

Exclusion Criteria

  • 1\.Patients with serious comorbidities such as moderate to severe pulmonary disease, neuromuscular disease, obesity hypoventilation syndrome, congestive heart failure, nocturnal arrythmias, 2\.patients with other sleep disorders involved such as central sleep apnea, periodic limb movement disorder, insomnia, parasomnias, circadian rhythm disorders, narcolepsy, REM sleep behavioural disorder, 3\.patients with painful TMD signs and symptoms according to DC/TMD, 4\.patients on narcotics or muscle relaxants, 5\.patients who had undergone oropharyngeal surgery, 6\.patients with severe cognitive impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials